When Medicare plays a major role in a company's business model there always seem to be challenges. Such is the case for Fresenius Medical Care (NYSE: FMS )
. While the company's strong global share in dialysis equipment and
strong share in North American dialysis services ought to be a strong
positive in the company's favor, the difficult reimbursement environment
has created challenges and uncertainties in the company's model. Though
there is a significant global growth in the number of patients with
end-stage renal disease, Fresenius Medical Care can't afford to drop the
ball when it comes to careful expense management.
Read more here:
Can Fresenius Medical Care AG & Co. Get Past Medicare Reimbursement Issues?
No comments:
Post a Comment